Attached files
| file | filename |
|---|---|
| EX-1.1 - EX-1.1 - rEVO Biologics, Inc. | d706707dex11.htm |
| EX-5.1 - EX-5.1 - rEVO Biologics, Inc. | d706707dex51.htm |
| EX-10.6 - EX-10.6 - rEVO Biologics, Inc. | d706707dex106.htm |
| EX-21.1 - EX-21.1 - rEVO Biologics, Inc. | d706707dex211.htm |
| EX-10.14 - EX-10.14 - rEVO Biologics, Inc. | d706707dex1014.htm |
| EX-10.15 - EX-10.15 - rEVO Biologics, Inc. | d706707dex1015.htm |
| EX-10.16 - EX-10.16 - rEVO Biologics, Inc. | d706707dex1016.htm |
| S-1/A - S-1/A - rEVO Biologics, Inc. | d706707ds1a.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Amendment No. 3 to the Registration Statement on Form S-1 of rEVO Biologics, Inc. of our report dated April 11, 2014, except for the effects of the restatement described in Note 2, and except for Note 18, as to which the date is July 25, 2014, and except for the effects of the reverse stock split described in Note 18, as to which the date is September 3, 2014, relating to the financial statements of rEVO Biologics, Inc., which appears in such Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
September 4, 2014